Illumina 2026년 2월 24일 Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top Players - Thermo Fisher Scientific, Pacific Biosciences, Illumina, Roche - Yahoo Finance Singapore
Illumina 2026년 2월 24일 The Bull Case For Illumina (ILMN) Could Change Following Buybacks And NovaSeq X Roadmap Reveal – Learn Why - simplywall.st
Illumina 2026년 2월 23일 Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector - DirectorsTalk Interviews
Illumina 2026년 2월 23일 Faster DNA decoding: Illumina’s NovaSeq X gets 40% more data, higher accuracy - Stock Titan
Illumina 2026년 2월 23일 Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - PR Newswire
Illumina 2026년 2월 23일 Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - Illumina
Illumina 2026년 2월 21일 Illumina Beat Q4 Earnings and Closed a $350M Acquisition. Here’s What Investors Need to Know - TIKR.com
Illumina 2026년 2월 19일 Scrappy San Diego startup goes toe-to-toe with gene-sequencing giant Illumina - San Diego Union-Tribune
Illumina 2026년 2월 19일 Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance
Illumina 2026년 2월 18일 Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com
Illumina 2026년 2월 17일 A Look At Illumina (ILMN) Valuation After Profitability Gains And SomaLogic Acquisition Guidance - simplywall.st
Illumina 2026년 2월 16일 Decoding early synaptic failure in Alzheimer’s disease through multiomic analysis - Illumina
Illumina 2026년 2월 16일 Illumina’s AI-Driven Data Vision Is Expanding — Will Multiomics Integration Unlock a Transformational Edge? - Smartkarma
Illumina 2026년 2월 16일 Illumina: Weak Backlog Support and Rising Competitive Pressures Undermine 2026 Outlook, Justifying Sell Rating - TipRanks